Home>Topics>>Keeping The Faith On BioMimetic Therapeutics
Keeping The Faith On BioMimetic Therapeutics
By Stephen Simpson : It hasn't been easy to stay bullish on BioMimetic Therapeutics ( BMTI ), as the stock has stagnated while the company worked to resubmit its PMA for its Augment bone graft product. What's more, news about under-reported side-effects and over-promised for Medtronic's ( MDT ) ...
Read the rest of this article on Long Investing Ideas from Seeking Alpha